Pulse Biosciences Inc.
09/13/2021 | Press release | Archived content
Correspondence (Form CORRESP)
CORRESP
PULSE BIOSCIENCES, INC.
3957 Point Eden Way
Hayward, California 94545
September13, 2021
Via EDGAR
|
|
|
|
U.S. Securities and Exchange Commission |
|
|
Division of Corporation Finance |
|
|
Office of Life Sciences |
|
|
100 F Street, NE |
|
|
Washington, D.C. 20549-3561 |
|
|
Attention:Ms. Christine Westbrook |
|
|
|
|
|
Re: |
Pulse Biosciences, Inc. |
|
|
Registration Statement on Form S-3 |
|
|
Filed September 3, 2021 |
|
|
File No. 333-259330 |
|
|
|
|
|
Acceleration Request |
|
|
Requested Date: September 15, 2021 |
|
|
Requested Time: 4:00 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pulse Biosciences, Inc. (the "Company") hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-259330) (the "Registration Statement"), be declared effective at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.
The Company hereby authorizes Ken Stratton, the Company's General Counsel, to make such request on the Company's behalf.
The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Ken Stratton at (510) 905-1106 or [email protected].
|
|
||
|
|
Sincerely, |
|
|
PULSE BIOSCIENCES, INC. |
||
|
|
By: |
/s/ Sandra A. Gardiner |
|
Sandra A. Gardiner Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer |
|
|
|
|
cc: |
Darrin R. Uecker, Pulse Biosciences, Inc. |
|
|
Kenneth B. Stratton, Esq., Pulse Biosciences, Inc. |
|
|
Andrew D. Hoffman, Esq., Wilson Sonsini Goodrich & Rosati, P.C. |